House committee advances FY2020 funding bill giving NIH a $2 billion raise May 10, 2019Vol.45 No.19By Claire Dietz
FDA issues draft guidance on using real world data in drugs, biologics May 10, 2019Vol.45 No.19By Matthew Bin Han Ong
Conversation with The Cancer Letter Georgetown’s Weiner and Hackensack’s Pecora tell us how they created a consortium spanning 233 miles May 10, 2019Vol.45 No.19By Paul Goldberg
NCI approves Georgetown-Hackensack consortiumAre More Long-Distance Relationship In The Works? May 10, 2019Vol.45 No.19By Paul Goldberg
FreeTrials & Tribulations A comparison of study designs for estimating overdiagnosis in cancer screening May 03, 2019Vol.45 No.18By Barry Kramer and Philip C. Prorok
Martine Roussel, Elaine Ostrander, Timothy Ley, Harmit Malik, Staffan Normark and Moshe Oren are among newly elected National Academy of Sciences members May 03, 2019Vol.45 No.18
Conversation with The Cancer Letter Hirsch: Syapse collaboration with Amgen will focus on real world evidence and hematologic malignancies May 03, 2019Vol.45 No.18By Matthew Bin Han Ong
House subcommittee bill gives NIH a $2 billion raise in FY2020—but budget caps must be raised May 03, 2019Vol.45 No.18By Claire Dietz and Matthew Bin Han Ong
Guest Editorial Getting beyond the immunotherapy divide: a call to action May 03, 2019Vol.45 No.18By John H. Stewart and Robert A. Winn
